Literature DB >> 2665406

Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

R Ebert1, W Creutzfeldt.   

Abstract

The response of immunoreactive gastric inhibitory polypeptide (IR-GIP), immunoreactive insulin (IRI) and immunoreactive C-peptide (IR-C-peptide) to the ingestion of mixed liquid test meals containing 1031 kcal (550 ml) and 422 kcal was studied in 17 obese and 17 normal weight control subjects. When the 422 kcal load was ingested in a volume of 550 ml, the plasma IR-GIP response was significantly greater than in a volume of 225 ml at 15 and 30 min in lean and obese subjects, but the total integrated IR-GIP response was not significantly different between the obese and lean group. Also intraduodenal infusion of 150 ml (280 kcal) of the test meal elicited identical plasma IR-GIP concentrations in lean and obese subjects. An exaggerated IR-GIP response in obese subjects was seen only following the 1031 kcal load (integrated IR-GIP response: 23.6 +/- 1.9 in lean subjects vs 50.3 +/- 3.8 nmol/l/180 min in obese subjects; p less than 0.01). The IRI response was always significantly greater in obese than in lean subjects and not related to the GIP response. Fasting plasma IR-C-peptide levels were significantly elevated in obese subjects (lean: 0.52 +/- 0.04; obese: 1.42 +/- 0.12 nmol/l; p less than 0.005), but the postprandial integrated IR-C-peptide responses in the obese and lean group were identical, indicating decreased hepatic insulin extraction in obesity. It is concluded that an exaggerated IR-GIP response in obesity occurs only after ingestion of a high calorie meal probably as consequence of an increased gastric emptying rate and that the hyperinsulinemic response of obese subjects is not attributable to GIP hypersecretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665406     DOI: 10.1007/bf02581191

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  52 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

2.  Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.

Authors:  D Elahi; D K Andersen; J C Brown; H T Debas; R J Hershcopf; G S Raizes; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-08

3.  Radioimmunoassay of gastric inhibitory polypeptide and its release in morbid obesity and after jejuno-ileal bypass [proceedings].

Authors:  D L Sarson; H S Besterman; S R Bloom
Journal:  J Endocrinol       Date:  1979-05       Impact factor: 4.286

4.  Regulation of the gastric emptying of glucose.

Authors:  W Brener; T R Hendrix; P R McHugh
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

5.  Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.

Authors:  E L Mazzaferri; G H Starich; C K Lardinois; G D Bowen
Journal:  J Clin Endocrinol Metab       Date:  1985-08       Impact factor: 5.958

6.  Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.

Authors:  E L Mazzaferri; G H Starich; S T St Jeor
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

7.  Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.

Authors:  D L Sarson; P G Kopelman; H S Besterman; T R Pilkington; S R Bloom
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

8.  Downregulation of insulin receptors in obese man.

Authors:  J P Wigand; W G Blackard
Journal:  Diabetes       Date:  1979-04       Impact factor: 9.461

9.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

10.  Similar plasma GIP responses in obese and lean subjects after an oral test meal and after intraduodenal stimulation with fat and glucose.

Authors:  P F Amland; R Jorde; P G Burhol; K E Giercksky
Journal:  Int J Obes       Date:  1984
View more
  1 in total

Review 1.  Physiology of incretins in health and disease.

Authors:  Carolyn F Deacon; Bo Ahrén
Journal:  Rev Diabet Stud       Date:  2011-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.